Inhibitors of class I HDACs and of FLT3 combine synergistically against leukemia cells with mutant FLT3
类 HDAC 抑制剂和 FLT3 抑制剂可协同作用对抗具有突变 FLT3 的白血病细胞
期刊:Archives of Toxicology
影响因子:4.8
doi:10.1007/s00204-021-03174-1
Vanessa Wachholz #, Al-Hassan M Mustafa #, Yanira Zeyn, Sven J Henninger, Mandy Beyer, Melanie Dzulko, Andrea Piée-Staffa, Christina Brachetti, Patricia S Haehnel, Andreas Sellmer, Siavosh Mahboobi, Thomas Kindler, Walburgis Brenner, Teodora Nikolova, Oliver H Krämer
肿瘤
白血病
其它细胞
FCM
IF
IHC-P
WB
Human
STA5A